P21 Peptide: Ciliary Neurotrophic Factor (CNTF) Active Region, Synaptogenesis, and Neuroplasticity Assays
An analytical investigation into the nootropic peptide P21 (Ac-DGGLAG-NH2). Ciliary neurotrophic factor mimetic properties, blood-brain barrier penetration, BDNF upregulation, and hippocampal neurogenesis. P21 is a synthetic peptide mimetic derived from the active neutralizing epitope of Ciliary Neurotrophic Factor (CNTF residues 147–150).
- P21 is a synthetic peptide mimetic derived from the active neutralizing epitope of Ciliary Neurotrophic Factor (CNTF residues 147–150).
- Modified with an N-terminal acetyl group and C-terminal amide to provide enzymatic stability against central peptidase degradation.
- Inhibits neutralizing CNTF auto-antibodies and enhances endogenous BDNF (Brain-Derived Neurotrophic Factor) transcription.
- Stimulates adult neural progenitor cell proliferation and dendritic branching in the dentate gyrus of the hippocampus.
| CAS Registry Number | 1256333-87-7 |
|---|---|
| Molecular Formula | C31H54N10O9 |
| Molecular Mass | 710.83 g/mol |
| Primary Biological Target | Ciliary Neurotrophic Factor Receptor (CNTFR) & BDNF/TrkB Signaling |
| Analytical Purity Standard | ≥99.0% (RP-HPLC, C18, 214/220 nm) |
| Identity Verification | ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%) |
| Lyophilized Storage | -20°C desiccated, protected from UV light (24–36 months) |
| Reconstituted Storage | 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water) |
1. Rational Design from Ciliary Neurotrophic Factor (CNTF)
Ciliary Neurotrophic Factor (CNTF) is a potent neurocytokine that promotes survival and differentiation of motor neurons and hippocampal progenitor cells. However, full-length recombinant CNTF has a short half-life (<3 minutes), poor blood-brain barrier permeability, and induces neutralizing antibodies. P21 is a stabilized peptide mimetic designed from CNTF's neurogenic epitope with an added tetrapeptide carrier: Ac-Asp-Gly-Gly-Leu-Ala-Gly-NH2 (MW 710.83 g/mol). Capping at both termini prevents rapid carboxypeptidase and aminopeptidase degradation.
2. Mechanism: BDNF Upregulation and Synaptic Plasticity
In-vitro assays in primary hippocampal and cortical neuron cultures show that P21 increases the phosphorylation of CREB (cAMP response element-binding protein) and upregulates BDNF and GDNF gene expression. Patch-clamp electrophysiology reveals that P21 enhances long-term potentiation (LTP) at CA1-CA3 Schaffer collateral synapses, increasing synaptophysin and PSD-95 expression.
3. Neurogenesis in the Subgranular Zone of the Dentate Gyrus
In 5-bromo-2'-deoxyuridine (BrdU) incorporation and doublecortin (DCX) staining assays, P21 administration significantly increases the proliferation and survival of adult neural stem cells in the subgranular zone (SGZ) of the dentate gyrus. Newly generated neuroblasts demonstrate proper morphological differentiation and functional integration into hippocampal neural circuitry.
4. Laboratory Preparation and Solubility
P21 is a neutral-to-hydrophilic peptide that dissolves cleanly in sterile Bacteriostatic Water or physiological saline at concentrations exceeding 15 mg/mL. Lyophilized stocks should be stored at -20°C in the dark. Reconstituted working solutions remain stable for up to 30 days at 2°C to 8°C.
5. Bench Preparation & Assay Reproducibility for P21 Peptide
When designing in-vitro experiments targeting Ciliary Neurotrophic Factor Receptor (CNTFR) & BDNF/TrkB Signaling, normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (710.83 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.
Peer-Reviewed References & Analytical Standards
- Li B. et al. (2010). Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice. FEBS Letters, 584(15), 3359–3365. [PMID: 20600002 ↗]
- Kazim S.F. et al. (2014). Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Neurobiology of Disease, 71, 110–130. [PMID: 25046994 ↗]
Referenced Laboratory Research Reagents
Batch-verified SwissLab catalog entries cited in this monograph
All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.